Rational Advisors LLC Bristol Myers Squibb CO Transaction History

Rational Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $881,762 - $1 Million	13,419 New	13,419 $930,000
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $5,312 - $6,019	-92 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $4,307 - $4,773	-75 Reduced 44.91%	92 $6,000
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $9,154 - $10,703	167 New	167 $10,000
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $5,382 - $7,821	-116 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$49.21 - $64.19 $1.42 Million - $1.85 Million	-28,781 Reduced 99.6%	116 $7,000
Q3 2019 Nov 06, 2019	BUY	$42.77 - $50.71 $295,412 - $350,253	6,907 Added 31.41%	28,897 $1.47 Million
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $435,401 - $481,459	9,758 Added 79.77%	21,990 $997,000
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $515,947 - $615,203	11,435 Added 1434.76%	12,232 $583,000
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $931,754 - $1.21 Million	-19,109 Reduced 96.0%	797 $41,000
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $730,384 - $823,816	-13,234 Reduced 39.93%	19,906 $1.24 Million
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $1.67 Million - $2.09 Million	33,109 Added 106803.23%	33,140 $1.84 Million
Q1 2018 May 18, 2018	BUY	$59.92 - $68.98 $1,857 - $2,138	31 New	31 $2,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Rational Advisors LLC with notifications on news.